OUROFINO S.A. — Investor Relations & Filings
Ourofino S.A. specializes in the research, development, production, and commercialization of veterinary pharmaceuticals and agro-science solutions. The company operates through specialized divisions focused on animal health and crop protection. Its animal health portfolio encompasses a comprehensive range of vaccines, medicines, and veterinary drugs designed for livestock and companion animals. In the agro-science sector, the organization utilizes advanced manufacturing facilities to produce modern crop protection products. Ourofino serves a broad market including farmers, agribusinesses, cooperatives, and retailers, supported by an extensive commercial and technical team. The company prioritizes the integration of innovative technologies to address global agricultural and veterinary requirements, providing integrated solutions across the agribusiness value chain.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| - | 2026-06-02 | Portuguese | |
| FRE - Formulário de Referência | 2026-06-02 | Portuguese | |
| Reconhecer a renúncia apresentada pelo conselheiro de administração Sr. Hiroshi Kakio, conforme carta de renúncia apresentada à Companhia em 15 de maio de 2026, que fica arquivada na sede social da Co | 2026-06-02 | Portuguese | |
| FCA - Formulário Cadastral | 2026-05-26 | Portuguese | |
| Informe do Código de Governança | 2026-05-19 | Portuguese | |
| FRE - Formulário de Referência | 2026-05-05 | Portuguese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
8 filings
| |||||
| 47958329 | - | 2026-06-02 | Portuguese | ||
| 47958326 | FRE - Formulário de Referência | 2026-06-02 | Portuguese | ||
| 47958255 | Reconhecer a renúncia apresentada pelo conselheiro de administração Sr. Hiroshi Kakio, conforme carta de renúncia apresentada à Companhia em 15 de maio de 2026, que fica arquivada na sede social da Co | 2026-06-02 | Portuguese | ||
| 47845764 | FCA - Formulário Cadastral | 2026-05-26 | Portuguese | ||
| 46695521 | Informe do Código de Governança | 2026-05-19 | Portuguese | ||
| 41986070 | FRE - Formulário de Referência | 2026-05-05 | Portuguese | ||
| 33696104 | - | 2026-04-06 | Portuguese | ||
| 33797878 | DFP 2025 | 2026-03-05 | Portuguese | ||
|
2025
6 filings
| |||||
| 34114318 | ITR 2025-Q3 | 2025-11-06 | Portuguese | ||
| 34114354 | ITR 2025-Q2 | 2025-08-07 | Portuguese | ||
| 46905060 | FRE WEB 2025 | 2025-05-26 | Portuguese | ||
| 34114254 | ITR 2025-Q1 | 2025-05-15 | Portuguese | ||
| 33788850 | DFP 2024 v2 | 2025-03-17 | Portuguese | ||
| 33788814 | DFP 2024 | 2025-03-13 | Portuguese | ||
|
2024
1 filing
| |||||
| 46903695 | FRE WEB 2024 v4 | 2024-11-11 | Portuguese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
CORCEPT THERAPEUTICS INC
Develops and commercializes cortisol-modulating medications…
|
CORT | US | Manufacturing |
|
Corline Biomedical AB
Develops heparin-based solutions for medical devices and re…
|
CLBIO | SE | Manufacturing |
|
CorMedix Inc.
Biopharma firm developing therapeutics for infectious and i…
|
CRMD | US | Manufacturing |
|
Corona Remedies Limited
Develops and manufactures therapeutic solutions across dive…
|
CORONA | IN | Manufacturing |
|
Corvus Pharmaceuticals, Inc.
Clinical-stage biopharma developing therapies for immune di…
|
CRVS | US | Manufacturing |
|
COSCIENS Biopharma Inc.
Develops and commercializes natural-based active ingredient…
|
CSCI | CA | Manufacturing |
|
Cosma Spolka Akcyjna
Manufactures and distributes hemp and cannabis products for…
|
COS | PL | Manufacturing |
|
COSMO Pharmaceuticals N.V.
A specialty pharmaceutical firm focused on gastroenterology…
|
COPN | NL | Manufacturing |
|
Cosmos Health Inc.
Vertically integrated healthcare group in the nutraceutical…
|
COSM | US | Manufacturing |
|
Cotinga Pharmaceuticals Inc.
Clinical-stage biopharma developing AI-driven therapeutics …
|
COT | CA | Manufacturing |
OUROFINO S.A. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/53118/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=53118 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=53118 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=53118 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 53118}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for OUROFINO S.A. (id: 53118)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.